Search for: "Fournier Industrie et Sante'" Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Mar 2008, 12:49 pm
Eighteen states and the District of Columbia have filed suit against Abbott Laboratories and Solvay’s Fournier Industrie et Santé and Laboratories Fournier for allegedly entering into a scheme to block the generic version of the cholesterol lowering drug TriCor ®   (fenofibrate), indicated for the treatment of hypercholesterolemia and hypertriglyceridemia. [read post]
13 Nov 2008, 5:27 pm
As of July 2008, twenty-five states and the District of Columbia have filed antitrust suits against Abbott Laboratories and Solvay's Fournier Industrie et Santé and Laboratories Fournier in Delaware District Court, charging them with blocking generic competition by engaging in product hopping, among other “anti-generic strategies. [read post]
20 Mar 2008, 8:48 am
District Court 1:08-CV-00155 (filed March 18, 2008).A group of eighteen states and the District of Columbia filed a complaint in Delaware District Court against Abbot Laboratories, Fournier Industrie et Sante and Laboratoires Fournier S.A. under the Sherman Act, alleging an unlawful monopolization of the fenofibrate market. [read post]
8 Jan 2010, 12:01 pm
Pharmaceutical Companies Agree to Settle Multi-State Antitrust SuitThis posting was written by Jeffrey May, Editor of CCH Trade Regulation Reporter.Abbott Laboratories and Fournier Industrie et Sante and Laboratories Fournier, S.A. have agreed to settle an antitrust action brought by 23 states and the District of Columbia, alleging that they conspired to block generic competition for the cholesterol-lowering drug Tricor. [read post]
28 Sep 2018, 9:46 am by Arianne Bouchard
Fournier, 2018 QCCQ 6747 [1] The decision on the merits was rendered on March 1, 2018 (2018 QCCQ 1071). [2] 2018 QCCQ 6747. [read post]
28 Sep 2018, 9:46 am by Arianne Bouchard
Both the firefighters and the investigators from the Commission des normes, de l’équité, de la santé et de la sécurité du travail (the “CNESST” – Quebec’s workplace health and safety board) who were on scene shortly after the accident, stated that the workplace presented an enormous hazard for the trench walls to collapse. [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense to Walker… [read post]
28 Mar 2008, 6:00 am
– GIs and the wine industry: (Canadian Trademark Blog) ChinaWorkTools: ‘We won the judgement but it did no good’ Part II: (IP Dragon),How should China spend its extra Yuan on IPR enforcement? [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]